Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks
Crossref DOI link: https://doi.org/10.1007/s40290-017-0198-2
Published Online: 2017-07-13
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fujikawa, Makoto
Ono, Shunsuke
License valid from 2017-07-13